Literature DB >> 22137582

Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths.

Amy Abruzzi1, Bernard Fried.   

Abstract

This review examines coinfection of selected species of Schistosoma with bacteria, protozoa and helminths and focuses on the effects of the coinfection on the hosts. The review is based mainly on tables that contain the salient information on the coinfecting organisms in vertebrate hosts. Further explanation and clarification of the tables are given in the text. A table is also provided that gives synoptic information on the 37 species in the 19 genera considered in this review. Coinfection studies with Schistosoma species and the other organisms were considered in six tables plus the accompanying text. Considerations of the Schistosoma interactions with another species of organism include studies on coinfection with Plasmodium, with protozoa other than Plasmodium; with Salmonella, with bacteria other than Salmonella; and with Fasciola, with helminths other than Fasciola. Numerous factors were found to influence the effects of coinfection on the vertebrate host, including organisms and hosts used in the studies, order and time interval between the first and the second infection, studies on natural versus experimental hosts, dosage of the infectious agents, strains and pedigrees of the parasites, age of hosts at time of exposure to the infectious agents and age of hosts at the time of necropsy. Overall, a prior infection with Schistosoma, particularly a patent infection, often has an effect on the subsequent infection by a protozoan, bacterium or other helminth. In relatively few cases, a prior infection with Schistosoma decreased the severity of the subsequent infection as with Helicobacter pylori, Fasciola hepatica, Echinostoma or Plasmodium, the latter only exhibiting this behaviour when coinfected with Schistosoma haematobium. More often, however, a prior infection with Schistosoma increased the severity of the second infection as with Leishmania, Toxoplasma gondii, Entamoeba histolytica, Staphylococcus aureus or Salmonella. In some of these coinfection studies, the increased severity of the subsequent infection was associated with a specific, prolonged form of the disease in humans, which has implications for patient treatment and recovery. Additional research is needed, particularly on Schistosoma coinfections which currently have a small body of research and are current problems in human populations. Examples of such Schistosoma interactions include the genera of Mycobacteria, Leishmania, Staphylococcus, Necator and Strongyloides. Hopefully, future studies will elucidate valuable new information on the interesting subject of coinfection of Schistosoma with other organisms.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22137582     DOI: 10.1016/B978-0-12-391429-3.00005-8

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  25 in total

1.  Effect of different stages of Schistosoma mansoni infection on the parasite burden and immune response to Strongyloides venezuelensis in co-infected mice.

Authors:  Michelle Carvalho de Rezende; Emília Souza Araújo; João Marcelo Peixoto Moreira; Vanessa Fernandes Rodrigues; Jailza Lima Rodrigues; Cíntia A de Jesus Pereira; Deborah Negrão-Corrêa
Journal:  Parasitol Res       Date:  2015-09-09       Impact factor: 2.289

Review 2.  Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer.

Authors:  Jared Honeycutt; Olfat Hammam; Chi-Ling Fu; Michael H Hsieh
Journal:  Trends Parasitol       Date:  2014-06-06

3.  Helminth-induced interleukin-4 abrogates invariant natural killer T cell activation-associated clearance of bacterial infection.

Authors:  Yi-Ju Hsieh; Chi-Ling Fu; Michael H Hsieh
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

4.  Impact of Coinfection with Schistosoma mansoni on the Antibody Response to Helicobacter pylori.

Authors:  Ashraf Fawzy Mosa Ahmed; Mona Hassan El-Sayad; Hala Shehata Ali; Hend Aly El-Taweel
Journal:  Acta Parasitol       Date:  2021-02-17       Impact factor: 1.440

5.  S. mansoni bolsters anti-viral immunity in the murine respiratory tract.

Authors:  Sebastian Scheer; Christine Krempl; Carsten Kallfass; Stefanie Frey; Thilo Jakob; Gabriel Mouahid; Hélène Moné; Annette Schmitt-Gräff; Peter Staeheli; Marinus C Lamers
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

Review 6.  Novel therapeutic and prevention approaches for schistosomiasis: review.

Authors:  Rashika A F El Ridi; Hatem A-M Tallima
Journal:  J Adv Res       Date:  2012-06-23       Impact factor: 10.479

7.  Association of eumycetoma and schistosomiasis.

Authors:  Jaap J van Hellemond; Alieke G Vonk; Corné de Vogel; Rob Koelewijn; Norbert Vaessen; Ahmed H Fahal; Alex van Belkum; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2013-05-23

8.  The Rapid-Heat LAMPellet Method: A Potential Diagnostic Method for Human Urogenital Schistosomiasis.

Authors:  Javier Gandasegui; Pedro Fernández-Soto; Cristina Carranza-Rodríguez; José Luis Pérez-Arellano; Belén Vicente; Julio López-Abán; Antonio Muro
Journal:  PLoS Negl Trop Dis       Date:  2015-07-31

9.  Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni.

Authors:  Christopher Khayeka-Wandabwa; Helen Kutima; Venny C S Nyambati; Johnstone Ingonga; Elijah Oyoo-Okoth; Lucy Karani; Bernard Jumba; Kiige Githuku; Christopher O Anjili
Journal:  Parasit Vectors       Date:  2013-08-22       Impact factor: 3.876

10.  In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine.

Authors:  Edward Yepes; Rubén E Varela-M; Julio López-Abán; El Habib Dakir; E L Habib Dakir; Faustino Mollinedo; Antonio Muro
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.